Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Amphastar Pharmaceuticals, Inc. develops, manufactures, markets, and sells complex generic and proprietary injectable, inhalation, and intranasal pharmaceutical products, along with insulin active pharmaceutical ingredients (APIs). The company targets high-barrier markets such as injectables and inhalation therapies, serving hospitals, clinics, and pharmacies primarily in the U.S. Amphastar’s vertically integrated model combines advanced R&D, manufacturing, and regulatory expertise to deliver technically challenging drugs with limited competition and strong supply chain control.
This description was generated via AI from an annual report. Updated about 1 year ago.